Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR)

NCT07359313 · tracked via the Priya Life Science Germany tracker

Sponsor

University Hospital Freiburg

Phase

Not applicable

Started

2026-01-07

Last updated

2026-01-22

Condition(s) studied

Cardiac Arrest (CA)

Investigational drug(s) / intervention(s)

colonoscopy

colonoscopy: bedside colonoscopy without bowel cleansing early (24-36h) after successful CPR

Study summary

Bedside colonoscopy 24-36 hours after successful CPR

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * adult patients (≥ 18 years) admitted to the participating department AND * in-hospital or out-of-hospital cardiac arrest (IHCA, OHCA) Exclusion Criteria: * resuscitation period of ≤ 5 minutes * awake and contactable patients (GCS ≥ 13)

Primary outcome measure(s)

Detection of colon ischemia — from baseline (0 hours) until day 30
Detection of colon ischemia within 30 days after return of spontaneous circulation

Trial sites (1)

Facility	City	Region	Status
Medical Center - University of Freiburg	Freiburg im Breisgau	Germany

More University Hospital Freiburg trials in Germany

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood Recruiting

Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small Bowel Recruiting

Developing Strategies to Facilitate Consent of Legally Authorized Representatives to Clinical Trials Recruiting

Pathogen-microbiome Interaction During Helicobacter Pylori Infection Recruiting

Serial Biomarker Testing and Cardiovascular Risk Stratification (ACHILLES) Active, not recruiting

Other trials for the same condition

A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support Recruiting

PEEP vs. ZEEP in Out-of-Hospital-Cardiac-Arrest Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07359313 on ClinicalTrials.gov ↗ ← All trials in Germany